ORIGINAL ARTICLE. Extreme Aggressiveness and Lethality of Gastric Adenocarcinoma in the Very Young. the general population
|
|
- Douglas Christopher Evans
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Extreme Aggressiveness and Lethality of Gastric Adenocarcinoma in the Very Young Brian R. Smith, MD; Bruce E. Stabile, MD Objective: To determine whether very young patients with gastric adenocarcinoma as compared with older patients with the disease have a biologically more aggressive form of the disease, presenting at an advanced stage and conferring unusually poor perioperative and longterm outcomes. Design, Setting, and Patients: A 15-year, singleinstitution, retrospective review and analysis of demographic and outcomes data for 350 patients diagnosed with gastric adenocarcinoma. Main Outcome Measures: Histologic features, frequency of stage IV disease, frequency of curative gastric resection, postoperative mortality, and long-term survival in very young and older patient groups. Results: Of 350 total patients, 30 (9%) were aged 35 years or younger. Very young patients (aged 35 years) as compared with older patients (aged 35 years) more often had diffuse-type tumor histologic findings (93% vs 69%, respectively; P=.003), adjacent organ invasion (74% vs 29%, respectively; P =.001), nodal metastases (94% vs 70%, respectively; P=.046), distant metastases (81% vs 50%, respectively; P=.003), and stage IV disease (90% vs 64%, respectively; P=.007). Potentially curative gastrectomy was accomplished in 58% of older patients but only 17% of very young patients (P=.001). Nontherapeutic operations were performed in only 6% of older patients but 33% of very young patients (P=.002). Very young patients as compared with older patients had high postoperative mortality (22% vs 2%, respectively; P=.003) related to advanced-stage disease. Mean survival was 33.4 months among older patients compared with only 11.6 months for very young patients (P=.02). Conclusions: Very young patients (aged 35 years) with gastric adenocarcinoma have significantly higher incidences of diffuse-type tumor histologic findings and both locally advanced and metastatic disease at presentation. These findings confirm a more aggressive tumor biology that results in often futile surgical interventions and an unusually grave prognosis. Strategies for earlier diagnosis together with effective new therapies are desperately needed to attenuate the extreme lethality in these uniquely unfortunate patients. Arch Surg. 09;144(6): Author Affiliations: Department of Surgery, University of California, Irvine Medical Center, Orange (Dr Smith); and Department of Surgery, Harbor-UCLA Medical Center, Torrance, California (Dr Stabile). WHILE GASTRIC ADenocarcinoma in the general population remains a deadly disease with poor outcomes, younger patients may have a particularly poor prognosis. Whereas the average patient age at presentation is approximately years, the relatively high mortality is largely attributable to the advanced stage of disease at diagnosis regardless of age. 1 Clinical observation has suggested that very young patients have a far worse prognosis than their older counterparts. As a logical extension of this observation, we hypothesized that examination of cohorts of very young patients with gastric adenocarcinoma would reveal a biologically more aggressive form of the disease that correlates with distinctly inferior surgical results and longterm survival. With regard to perioperative outcomes, the recognized liabilities of nontherapeutic laparotomy were anticipated to be manifestly exaggerated in this youthful population. Thus, there may be 2 distinct adverse factors operative in the very young, namely an excessive early postoperative mortality and severely limited longevity consequent to an aggressive tumor biology and advanced disease. To validate this hypothesis, a 15-year retrospective study of all patients diagnosed with gastric adenocarcinoma at a single institution was undertaken. METHODS A retrospective review that included all patients diagnosed with gastric adenocarcinoma at Harbor-UCLA Medical Center between January 1, 1993, and December 31, 07, was con- 506
2 Stage IV Disease, % Age Cohort, y Figure 1. Frequency of stage IV gastric adenocarcinoma by age cohort. ducted. The medical center serves a large metropolitan area of southwestern Los Angeles County, California, with a patient population that is predominantly immigrant. A total of 350 such patients were encountered during this study period, and their clinical and pathologic information was culled from the hospital cancer registry database and from individual medical records. Specific details retrieved from the database included patient demographics, gastroscopic or surgical biopsy results, operative interventions, and clinical follow-up. Patients with diagnoses of gastric carcinoid tumor, lymphoma, and gastrointestinal stromal tumor were excluded. Specific information such as reports of endoscopic ultrasonography and abdominal computerized tomography, clinical and pathologic tumor staging, and gastric resective or other operative or interventional procedures for cure or palliation was acquired through individual medical record review. Outcome measures of interest included patient age at diagnosis, histologic tumor type, TNM stage, disease stage, surgical resectability, operation performed, completeness of resection, postoperative complications and deaths, and long-term survival. To define the appropriate age groups for comparison, the distribution of frequencies of stage IV (essentially incurable) disease by 5-year age cohorts was examined. The resulting natural age separation was used to define the very young and older patient groups. For purposes of age group comparisons, the data related to very young patients were compared with those of older patients. Statistical analyses were performed using the Fisher exact test for categorical data and the unpaired t test for comparison of group means. Kaplan-Meier actuarial survival curves were generated for both age groups and compared. P.05 was considered statistically significant. The institutional review board at Harbor- UCLA Medical Center approved the project. RESULTS A total of 350 patients with gastric adenocarcinoma were identified from the 15-year study interval. The mean age at presentation was 56.4 years (range, -94 years), and 55% were men. Ethnic proportions were as follows: Hispanic, 50%; Asian, 30%; African American, 11%; and white, 9%. The mean follow-up for all patients was 16.5 months. Although advanced-stage disease was common throughout the study population, the age cohort distribution of stage IV disease demonstrated 35 years as the threshold age that separated those patients with unusually advanced disease from those with less advanced disease (Figure 1). Therefore, the 30 patients (9%) aged 35 years or younger were classified as very young, and the 3 patients (91%) older than 35 years were classified as older. Ethnicity, sex, and year of presentation had no influence on disease stage. However, patients classified as very young more often had diffuse-type tumor histologic findings as well as the components of advancedstage disease such as transmural primary tumors with adjacent organ invasion (T4), nodal metastases (N1-3), and distant metastases (M1). All of these indicators of more aggressive tumor biology were significantly more common in the very young (Table). A total of 188 patients (54%) underwent operation, with similar rates of operation in both age groups (% in very young patients vs 53% in older patients; P=.57). 507
3 Table. Tumor Histologic Findings and Staging Data Tumor Histologic Findings or Staging Diffuse-type tumor histologic findings Tumor invasion of adjacent organs, T4 Lymph nodal metastases, N1-3 However, gastric resection was accomplished in only 56% of very young patients compared with 86% of older patients (P=.003). Notably, gastrectomy with negative histologic margins (R0) and curative potential was achieved in 58% of older patients but was possible in only 17% of very young patients (P=.001). In 3 of the 4 very young age cohorts, no patients could be afforded an R0 resection (Figure 2). With the exception of only 1 older age cohort (aged years) in which no gastric resections were performed, only the very young age cohorts had R0 resection rates of 25% or less. Furthermore, nontherapeutic laparotomies were performed in only 6% of older patients but in 33% of very young patients owing to their very advanced stage of disease (P=.002). The postoperative morbidity rates were similar (33% for very young patients vs 29% for older patients; P=.79), but the mortality rate for very young patients was significantly greater than that of their older counterparts (22% vs 2%, respectively; P=.003). Of note, 2 of the 4 postoperative deaths among the very young patients followed nontherapeutic laparotomies for unresectable tumors. The mean longterm survival was significantly greater for older patients at 33.4 months (95% confidence interval, months) compared with only 11.6 months (95% confidence interval, months) for very young patients (P=.02). Overall actuarial survival was likewise significantly greater among older patients (Figure 3). COMMENT No./ Total No. (%) Aged 35 y (n=30) Aged 35 y (n=3) P Value 28/30 (93) 211/306 (69) /23 (74) 62/213 (29) /17 (94) 144/6 (70).046 Distant metastases, M1 21/26 (81) 1/279 (50).003 Stage IV disease 26/29 (90) 4/317 (64).007 Although it is the second leading cause of cancer deaths worldwide, gastric adenocarcinoma ranks only 14th in cancer frequency in the United States. 2 Disparities in the global epidemiology of gastric adenocarcinoma have led to significant variance in the clinical outcomes of patients described as young. The mere definition of young has been widely interpreted to include patients ranging from younger than 30 years to up to 50 years. 3-9 Because our interest in this study was to determine whether very young patients with gastric adenocarcinoma have a more severe form of the disease, we initially investigated the frequencies of stage IV cancer along the continuum of 5-year age cohorts. There was an obvious cutoff at age 35 years that differentiated those with excessively advanced disease from those with less though still relatively advanced disease. As a result, our definition of very young has been confined to age 35 years and younger. Not surprisingly, among patients with gastric adenocarcinoma reported in the literature and arbitrarily described as young, there has been wide variation in their proportion, ranging from 6.8% to 14.8% of the entire patient population. 3,7 In our study, the age groups were defined by a natural separation based on disease stage at presentation. Nevertheless, the subset of very young patients constituted 9% of our study population and is not inconsistent with the findings of earlier reported series that used more arbitrary definitions of youthfulness. The data presented herein and those of several other series suggest a biologically more aggressive form of gastric adenocarcinoma in very young patients. 3,4 Specific histologic markers of aggressive biological behavior include poorly differentiated tumors with diffuse-type histologic findings and signet ring cells. Although the diffuse type of gastric adenocarcinoma is believed to be less common than the more differentiated intestinal type, it more often affects young patients and may be familial and dependent on an autosomal dominant, incomplete penetrance pattern of genetic inheritance. 10 A high level of microsatellite instability has been commonly found in gastric adenocarcinomas and is known to be associated with mutations in the coding and noncoding regions of a variety of cancer-related genes It is estimated that between 5% and 10% of gastric adenocarcinomas are genetic in origin. 14 Most of these cancers are of the diffuse type, and the most substantiated germline mutation is that of the CDH1 gene, which codes for the cellular adhesion molecule E-cadherin. The CDH1 germline mutation is associated with hereditary diffuse gastric cancer in about one-third of affected families and manifests phenotypically as linitis plastica. As the very young patients in this study were significantly more affected with tumors of diffuse-type histologic findings, the implication of a genetic basis for the disease in this population appears to be strong. Other indicators of the aggressive nature of gastric adenocarcinoma in young patients are the high rates of nodal and distant metastases found at diagnosis compared with those in older patients as well as the frequency of linitis plastica involving all or most of the stomach at surgical exploration. 7,8 Young patients also have been shown to have a high incidence of the caga-positive genotype of Helicobacter pylori infection that is known to be more virulent than infection by bacterial strains not harboring the gene. 5,15,16 Several studies have indicated that cagapositive H pylori infection substantially increases the odds ratio for cancer development compared with caganegative H pylori infection. 17,18 Although host genetic factors may play a more dominant oncogenic role in young patients, little doubt remains regarding the causal relationship between H pylori infection and the development of gastric adenocarcinoma. 19 Best estimates suggest that the infection plays an important etiologic role in more than 50% of all gastric adenocarcinomas worldwide. Despite our findings and those of previous studies that confirmed a more aggressive form of gastric adenocarcinoma in young patients, there have been 2 recent investigations from abroad that fail to support this con- 508
4 RO Resections, % Age Cohort, y Figure 2. Frequency of R0 (potentially curative) gastric resection by age cohort. Cumulative Survival, % 100 Age group 35 y >35 y 35 y, censored >35 y, censored Survival, mo Figure 3. Kaplan-Meier actuarial survival curves for very young (aged 35 years) and older (aged 35 years) age groups. clusion. Kulig et al 21 analyzed 214 affected Polish patients aged years and younger. Compared with 3217 older patients, there were no differences in tumor stage, postoperative morbidity or mortality, or long-term survival, although the young patients had a higher frequency of diffuse-type tumor histologic findings. Similarly, Lee et al 22 demonstrated in 54 Korean patients aged years and younger that higher frequencies of women, diffusetype tumors, and proximal gastric location of primary tumors were the only differences between young and older patients. No differences were found with regard to TNM stage, tumor size, or cumulative survival. Unfortunately, no operative data were contained in this latter study. While neither of these investigations confirmed our findings, both used an older age threshold of years that was chosen arbitrarily and may have inappropriately assigned lower-risk patients to the young age group. Furthermore, the Korean study did not compare the age groups for high rates of advanced T-stage tumors, nodal involvement, or distant metastatic disease. These markers of aggressive tumor behavior, together with a high frequency of diffuse-type histologic findings and low rates of resectability and survival, collectively provide the basis for our finding of a particularly malignant tumor biology in very young patients, at least in the United States. Future considerations for prevention of gastric cancer that is genetically based, aggressive, and appears early in life should include prophylactic gastrectomy. Young members of families with a history of hereditary diffuse gastric cancer who harbor the CDH1 germline mutation are candidates for such a preemptive intervention. 14 Because this cadre of patients represents only a very small minority of those affected, effective prevention for the majority awaits further elucidation of the genetic factors involved. Along with improved surgical and nonsurgical therapeutics, simple awareness of the problem of the extreme aggressiveness of gastric adenocarcinoma in younger patients is desperately needed at this time. Such awareness, together with new and effective screening methods to detect early-stage tumors, will be required to impact the dismal outcomes in these unfortunate individuals. 509
5 Accepted for Publication: March 21, 08. Correspondence: Bruce E. Stabile, MD, Department of Surgery, Harbor-UCLA Medical Center, 1000 W Carson St, Box 25, Torrance, CA (bstabile@ucla.edu). Author Contributions: Study concept and design: Stabile. Acquisition of data: Smith. Analysis and interpretation of data: Smith and Stabile. Drafting of the manuscript: Smith and Stabile. Critical revision of the manuscript for important intellectual content: Stabile. Statistical analysis: Smith. Administrative, technical, and material support: Stabile. Study supervision: Stabile. Financial Disclosure: None reported. Previous Presentation: This paper was presented at the 79th Annual Meeting of the Pacific Coast Surgical Association; February 18, 08; San Diego, California. REFERENCES 1. Hohenberger P, Gretschel S. Gastric cancer. Lancet. 03;362(93): Fenoglio-Preiser CM, Noffsinger AE, Belli J, Stemmermann GN. Pathologic and phenotypic features of gastric cancer. Semin Oncol. 1996;23(3): Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, Kim SK. Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients. World J Gastroenterol. 05;11(1): Hirahashi M, Yao T, Matsumoto T, et al. Intramucosal gastric adenocarcinoma of poorly differentiated type in the young is characterized by Helicobacter pylori infection and antral lymphoid hyperplasia. Mod Pathol. 07;(1): Rugge M, Busatto G, Cassaro M, et al. Patients younger than years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer. 1999;85(12): Llanos O, Butte JM, Crovari F, Duarte I, Guzman S. Survival of young patients after gastrectomy for gastric cancer. World J Surg. 06;30(1): Ramos-De la Medina A, Salgado-Nesme N, Torres-Villalobos G, Medina-Franco H. Clinicopathologic characteristics of gastric cancer in a young patient population. J Gastrointest Surg. 04;8(3): Koea JB, Karpeh MS, Brennan MF. Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients. Ann Surg Oncol. 00;7(5): Kim DY, Ryu SY, Kim YJ, Kim SK. Clinicopathological characteristics of gastric carcinoma in young patients. Langenbecks Arch Surg. 03;388(4): La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer. 1992;70(1): González CA, Sala N, Capellá G. Genetic susceptibility and gastric cancer risk. Int J Cancer. 02;100(3): Machado JC, Figueiredo C, Canedo P, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology. 03;125(2): Nardone G, Morgner A. Helicobacter pylori and gastric malignancies. Helicobacter. 03;8(suppl 1): Lynch HT, Grady W, Suriano G, Huntsman D. Gastric cancer: new genetic developments. J Surg Oncol. 05;90(3): Carvalho R, Milne A, van Rees BP, et al. Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. J Pathol. 04;4(1): Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease, part I. Curr Probl Surg. 05;42(11): Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between caga seropositivity and gastric cancer. Gastroenterology. 03; 125(6): Machida-Montani A, Sasazuki S, Inoue M, et al. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer. 04;7(1): Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease, part II. Curr Probl Surg. 05;42(12): Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 02;347(15): Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Jedrys J, Szczepanik AM; Polish Gastric Cancer Study Group. Clinicopathologic profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients. Langenbecks Arch Surg. 08;393(1): Lee JH, Ryu KW, Lee JS, et al. Decisions for extent of gastric surgery in gastric cancer patients: younger patients require more attention than the elderly. J Surg Oncol. 07;95(6):
Update on Hereditary Gastric Cancer. Dr. Savtaj Brar MD MSc Surgical Oncologist Assistant Professor of Surgery
Update on Hereditary Gastric Cancer Dr. Savtaj Brar MD MSc Surgical Oncologist Assistant Professor of Surgery Disclosures None Outline 1. Discuss new consensus guidelines on hereditary diffuse gastric
More informationClinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients
Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide
More informationB Breast cancer, managing risk of lobular, in hereditary diffuse gastric cancer, 51
Index Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, gastric. See also Gastric cancer. D2 nodal dissection for 57 70 Adjuvant therapy, for gastric cancer, impact of D2 dissection
More informationCancer of the Stomach
Cancer of the Stomach Review of Consecutive Ten Year Intervals KENNETH ADASHEK, M.D.,* JAMES SANGER, M.D.,t WILLIAM P. LONGMIRE, JR., M.D.* Records were reviewed for all patients who underwent primary
More informationClinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma
Original Article Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma Zhaode Bu, Zhixue Zheng, Ziyu Li, Xiaojiang Wu, Lianhai Zhang, Aiwen Wu,
More informationJun Lu, Chang-Ming Huang, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, and Jian-Xian Lin
Oncology Volume 22, Article ID 6428, 7 pages doi:.55/22/6428 Research Article Analysis on the Clinical and Pathological Features and Prognosis of Familial Gastric Cancer in South China Population: A Single-Center
More informationGastrointestinal Tract Cancer
Gastrointestinal Tract Cancer Tumors of the Stomach Gastric adenocarcinoma Incidence and Epidemiology Incidence mortality rates USA High incidence: Japan, China, Chile, Ireland risk lower socioeconomic
More informationHereditary Gastric Cancer
Hereditary Gastric Cancer Dr Bastiaan de Boer Consultant Pathologist Department of Anatomical Pathology PathWest Laboratory Medicine, QE II Medical Centre Clinical Associate Professor School of Pathology
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationPrognosis of Patients With Gastric Cancer Who Underwent Proximal Gastrectomy
Int Surg 2012;97:275 279 Prognosis of Patients With Gastric Cancer Who Underwent Proximal Gastrectomy Masahide Ikeguchi, Abdul Kader, Seigo Takaya, Youji Fukumoto, Tomohiro Osaki, Hiroaki Saito, Shigeru
More informationPerigastric lymph node metastases in gastric cancer: comparison of different staging systems
Gastric Cancer (1999) 2: 201 205 Original article 1999 by International and Japanese Gastric Cancer Associations Perigastric lymph node metastases in gastric cancer: comparison of different staging systems
More informationDisclosures. Gastric Intestinal Metaplasia and Early Gastric Cancer: Screening, Surveillance, and Endoscopic Therapy. ASGE Guidelines.
Gastric Intestinal Metaplasia and Early Gastric Cancer: Screening, Surveillance, and Endoscopic Therapy Consultant for: Olympus Medtronic US Endoscopy Disclosures Joo Ha Hwang, MD, PhD Associate Professor
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationConventional Gastrectomy for Gastric Cancer. Franklin Wright UCHSC Department of Surgery Grand Rounds January 14, 2008
Conventional Gastrectomy for Gastric Cancer Franklin Wright UCHSC Department of Surgery Grand Rounds January 14, 2008 Overview Gastric Adenocarcinoma Conventional vs Radical Lymphadenectomy Non-randomized
More informationAfter primary tumor treatment, 30% of patients with malignant
ESTS METASTASECTOMY SUPPLEMENT Alberto Oliaro, MD, Pier L. Filosso, MD, Maria C. Bruna, MD, Claudio Mossetti, MD, and Enrico Ruffini, MD Abstract: After primary tumor treatment, 30% of patients with malignant
More informationUtility of the Proximal Margin Frozen Section for Resection of Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative
Ann Surg Oncol (2014) 21:4202 4210 DOI 10.1245/s10434-014-3834-z ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Utility of the Proximal Margin Frozen Section for Resection of Gastric Adenocarcinoma: A 7-Institution
More informationExtended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis
Original Article Extended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis 1. Longbin Xiao, 2. Mingzhe Li, 3. Fengfeng Xu, Department of General Surgery I, 4. Huishao Ye, Department
More informationThe objective of this systematic review is to assess the impact of migration on the risk of developing gastric cancer.
Review title The effect of migration on gastric cancer risk: A systematic review protocol Reviewers Haejin In, MD, MBA, MPH 1 Marisa Langdon-Embry, MS 2 1 Albert Einstein College of Medicine, haejin.in@einstein.yu.edu
More informationA study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric cancer.
Biomedical Research 2018; 29 (2): 365-370 ISSN 0970-938X www.biomedres.info A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric
More informationSurgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study
Original article Annals of Gastroenterology (2013) 26, 346-352 Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study Subhankar Chakraborty
More informationESD for EGC with undifferentiated histology
ESD for EGC with undifferentiated histology Jun Haeng Lee, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Biopsy: M/D adenocarcinoma ESD: SRC >>
More informationAvances en patología gástrica. Novedades de la clasificación WHO (2010)
XXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology Avances en patología gástrica. Novedades de la clasificación WHO (2010) Fátima Carneiro
More informationAnalysis of the outcome of young age tongue squamous cell carcinoma
Jeon et al. Maxillofacial Plastic and Reconstructive Surgery (2017) 39:41 DOI 10.1186/s40902-017-0139-8 Maxillofacial Plastic and Reconstructive Surgery RESEARCH Open Access Analysis of the outcome of
More informationDOCTORAL THESIS SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF GASTRIC CARCINOMAS SUMMARY Scientific Coordinator: Univ. Prof. Dr. SIMIONESCU CRISTIANA EUGENIA
More informationGastric Cancer in a Young Postpartum Female. Kings County Hospital Center SUNY Downstate Case Conference May 24, 2012
Gastric Cancer in a Young Postpartum Female Kings County Hospital Center SUNY Downstate Case Conference May 24, 2012 Case HPI: 31 yo F, G5P3, 3 weeks s/p C-section, with gastric outlet obstruction. Pt
More informationClinical Outcomes of Endoscopic Submucosal Dissection in Patients under 40 Years Old with Early Gastric Cancer
ORIGINAL ARTICLE ISSN 1738-3331, http://dx.doi.org/10.7704/kjhugr.2016.16.3.139 The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2016;16(3):139-146 Clinical Outcomes of Endoscopic
More informationClinical Study Gastric Cancer in the Young: Is It a Different Clinical Entity? A Retrospective Cohort Study
Gastroenterology Research and Practice, Article ID 125038, 9 pages http://dx.doi.org/10.1155/2014/125038 Clinical Study Gastric Cancer in the Young: Is It a Different Clinical Entity? A Retrospective Cohort
More informationCharacteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu
ORIGINAL ARTICLE Characteristics of intramural metastasis in gastric cancer Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu Hishima Author for correspondence: T. Hashimoto
More informationImpact of infectious complications on gastric cancer recurrence
Gastric Cancer (2015) 18:368 374 DOI 10.1007/s10120-014-0361-3 ORIGINAL ARTICLE Impact of infectious complications on gastric cancer recurrence Tsutomu Hayashi Takaki Yoshikawa Toru Aoyama Shinichi Hasegawa
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationPrognostic analysis of gastric mucosal dysplasia after endoscopic resection: A single-center retrospective study
JBUON 2019; 24(2): 679-685 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Prognostic analysis of gastric mucosal dysplasia after endoscopic resection:
More informationNew developments in pathogenesis, gastric cancer. Matthias Ebert. II. Medizinische Klinik Klinikum rechts der Isar TU München
New developments in pathogenesis, diagnosis, therapy and prevention of gastric cancer Matthias Ebert II. Medizinische Klinik Klinikum rechts der Isar TU München Gastric Cancer Pathogenesis Diagnosis Treatment
More informationOutcome after emergency surgery in patients with a free perforation caused by gastric cancer
experimental and therapeutic medicine 1: 199-203, 2010 199 Outcome after emergency surgery in patients with a free perforation caused by gastric cancer Hironori Tsujimoto 1, Shuichi Hiraki 1, Naoko Sakamoto
More informationPoor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas
10 The Open Otorhinolaryngology Journal, 2011, 5, 10-14 Open Access Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas Kevin C. Huoh and Steven J. Wang * Head and Neck Surgery and Oncology,
More informationEsophageal cancer: Biology, natural history, staging and therapeutic options
EGEUS 2nd Meeting Esophageal cancer: Biology, natural history, staging and therapeutic options Michael Bau Mortensen MD, Ph.D. Associate Professor of Surgery Centre for Surgical Ultrasound, Upper GI Section,
More informationRisk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer
498 Original article Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer Authors C. Kunisaki 1, M. Takahashi 2, Y. Nagahori 3, T. Fukushima 3, H. Makino
More informationWHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?
CANCER STAGING TNM and prognosis in CRC WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER? Alessandro Lugli, MD Institute of Pathology University of Bern Switzerland Maastricht, June 19
More informationClinical Relevance of the Tumor Location-Modified Lauren Classification System of Gastric Cancer
pissn : 2093-582X, eissn : 2093-5641 J Gastric Cancer 2015;15(3):183-190 http://dx.doi.org/10.5230/jgc.2015.15.3.183 Original Article Clinical Relevance of the Tumor Location-Modified Lauren Classification
More informationResearch Article Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy
International Surgical Oncology Volume 2012, Article ID 307670, 7 pages doi:10.1155/2012/307670 Research Article Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy
More informationPrognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy
pissn : 293-582X, eissn : 293-564 J Gastric Cancer 26;6(3):6-66 http://dx.doi.org/.523/jgc.26.6.3.6 Original Article Prognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy
More informationUniversity Mainz. Early Gastric Cancer. Ralf Kiesslich. Johannes Gutenberg University Mainz, Germany. Early Gastric Cancer 15.6.
Ralf Kiesslich Johannes Gutenberg University Mainz, Germany DIAGNOSIS Unmask lesions - Chromoendoscopy -NBI Red flag technology - Autofluorescence Surface and detail analysis - Magnifying endoscopy - High
More informationTest Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar
Link full download:https://getbooksolutions.com/download/test-bank-for-robbinsand-cotran-pathologic-basis-of-disease-9th-edition-by-kumar Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th
More informationEvaluation of prognostic scoring systems for bone metastases using single center data
MOLECULAR AND CLINICAL ONCOLOGY 3: 1361-1370, 2015 Evaluation of prognostic scoring systems for bone metastases using single center data HIROFUMI SHIMADA 1, TAKAO SETOGUCHI 2, SHUNSUKE NAKAMURA 1, MASAHIRO
More informationESMO Preceptorship Gastric cancer Brussels 4-5 September 2015
www.esmo.org ESMO Preceptorship Gastric cancer Brussels 4-5 September 2015 Gastric cancer Multidisciplinary management, standards of care, therapeutic targets and future perspectives Fátima Carneiro IPATIMUP
More informationCáncer gástrico familiar y hereditario
XXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology NEOPLASIAS HEREDITARIAS Cáncer gástrico familiar y hereditario Fátima Carneiro IPATIMUP
More informationGastric Carcinoma in Young Adults. Hitoshi Katai, Mitsuru Sasako, Takeshi Sano and Keiichi Maruyama
Gastric Carcinoma in Adults Hitoshi Katai, Mitsuru Sasako, Takeshi Sano and Keiichi Maruyama Department of Surgical Oncology, National Cancer Center Hospital, Tokyo ' Among 4608 patients with gastric carcinoma
More informationThe Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon
The Royal Marsden Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon Any surgeon can cure Surgeon - dependent No surgeon can cure EMR D2 GASTRECTOMY
More informationRevisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis
Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,
More informationTest Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar
Link full download: http://testbankair.com/download/test-bank-for-robbins-cotran-pathologic-basis-of-disease-9th-edition-bykumar-abbas-and-aster Test Bank for Robbins and Cotran Pathologic Basis of Disease
More informationSignificance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories
Original Article Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Wu Song, Yulong He, Shaochuan Wang, Weiling
More informationClinicopathologic and prognostic factors of young and elderly patients with esophageal adenocarcinoma: is there really a difference?
Diseases of the Esophagus (2008) 21, 596 600 DOI: 10.1111/j.1442-2050.2008.00817.x Original article Clinicopathologic and prognostic factors of young and elderly patients with esophageal adenocarcinoma:
More informationThe Association of CagA + Helicobacter pylori Infection and Gastric Carcinoma
The Association of CagA + Helicobacter pylori Infection and Gastric Carcinoma PRESENTER: Dr. Md. Khalilur Rahman Student of M.D.(Internal Medicine) Sylhet MAG Osmani Medical College Gastric Cancer- ranked
More informationGASTROINTESTINAL METASTASES FROM LOBULAR BREAST CANCER
42. 1,. 1,. 2,. 2. 1 1, 2, GASTROINTESTINAL METASTASES FROM LOBULAR BREAST CANCER V. Gerova 1, L. Tankova 1, A. Mihova 2, I. Drandarsk 2 and H. Kadian 1 1 Clinic of Gastroenterology, University Hospital
More informationCase Report Intramucosal Signet Ring Cell Gastric Cancer Diagnosed 15 Months after the Initial Endoscopic Examination
Hindawi Publishing Corporation Case Reports in Medicine Volume 2015, Article ID 479625, 5 pages http://dx.doi.org/10.1155/2015/479625 Case Report Intramucosal Signet Ring Cell Gastric Cancer Diagnosed
More informationMr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer
Mr Chris Wakeman General Surgeon University of Otago, Christchurch 12:15-12:40 Management of Colorectal Cancer Bowel cancer Chris Wakeman Colorectal Surgeon Christchurch Sam Simon (Simpsons) Elizabeth
More informationMucinous Adenocarcinoma of the Stomach Clinicopathological
THE KURUME MEDICAL JOURNAL Vo1. 43, p. 289-294, 1996 ORIGINAL ARTICLE Mucinous Adenocarcinoma of the Stomach Clinicopathological Studies KIKUO KOUFUJI, JINRYO TAKEDA, ATSUSHI TOYONAGA, ISSEI KODAMA, KEISHIRO
More informationEthnic Distribution of Atrophic Autoimmune Gastritis in the United States
Ethnic Distribution of Atrophic Autoimmune Gastritis in the United States Robert M. Genta, Regan Allen, Massimo Rugge Miraca Life Sciences Research Institute, Miraca Life Sciences, Irving, Texas UTSW University
More informationShort and longterm outcomes after endoscopic resection of malignant polyps.
Short and longterm outcomes after endoscopic resection of malignant polyps. Short and longterm outcomes High risk features Lymph node metastasis Lymph node metastases sm1 sm2 sm3 Son 2008 3.1 % 14.9% 25.0
More informationDisclosure of Relevant Financial Relationships
Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
More informationGastric Cancer: Surgery and Regional Therapy. Epidemiology. Risk factors
Gastric Cancer: Surgery and Regional Therapy Timothy J. Kennedy, MD Montefiore Medical Center Assistant Professor of Surgery Upper Gastrointestinal and Pancreas Surgery December 15, 2012 1 Epidemiology
More informationEndoscopic Ultrasonography Assessment for Ampullary and Bile Duct Malignancy
Diagnostic and Therapeutic Endoscopy, Vol. 3, pp. 35-40 Reprints available directly from the publisher Photocopying permitted by license only (C) 1996 OPA (Overseas Publishers Association) Amsterdam B.V.
More informationORIGINAL ARTICLE. Pathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection. with adrenocortical carcinoma
ORIGINAL ARTICLE Pathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection Lawrence E. Harrison, MD; Paul B. Gaudin, MD; Murray F. Brennan, MD Objective: To identify
More informationTechnical and Endoscopic Factors in. in CDH1 Mutation Carriers
Technical and Endoscopic Factors in Gastric Cancer Surveillance in CDH Mutation Carriers Carol A. Burke,3,5, Michael Cruise 2,5, Lisa LaGuardia 3,5, Margaret O Malley 3,5, Matthew Kalady 3,5, James Church
More informationGastrointestinal pathology 2018 lecture 4. Dr Heyam Awad FRCPath
Gastrointestinal pathology 2018 lecture 4 Dr Heyam Awad FRCPath Topics to be covered Peptic ulcer disease Hiatal hernia Gastric neoplasms Peptic ulcer disease (PUD)= chronic gastric ulcer Causes H pylori
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationLong-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules
Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA
More informationThe Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum
The Royal Marsden Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum The Royal Marsden William Allum Conflict of Interest None Any surgeon can cure Surgeon - dependent
More informationORIGINAL ARTICLE. International Journal of Surgery
International Journal of Surgery (2013) 11(S1), S90 S94 Contents lists available at ScienceDirect International Journal of Surgery journal homepage: www.journal-surgery.net ORIGINAL ARTICLE Lymph node
More informationSCIENTIFIC PAPER ABSTRACT INTRODUCTION METHODS
SCIENTIFIC PAPER Prophylactic Laparoscopic Gastrectomy for Hereditary Diffuse Gastric Cancer: A Case Series in a Single Family David Hackenson, BS, David A. Edelman, MD, Tim McGuire, MD, Donald W. Weaver,
More informationInternational Journal of Medical Science and Health Research
A Retrospective Study of Clinicopathological Profiles of Proximal Gastrectomy Vs Distal Gastrectomy in Carcinoma Stomach and Its Incidence in our Population Dr Magesh kumar J 1, Dr V Naveen Kumar 2, Dr
More informationDisclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose
Tumor Budding in Colorectal Carcinoma: What, Why, and How Disclosures I have nothing to disclose Soo-Jin Cho, MD, PhD Assistant Professor UCSF Dept of Pathology Current Issues in Anatomic Pathology 2017
More informationStaging Laparoscopy in the Management of Gastric Cancer: A Population-Based Analysis
Staging Laparoscopy in the Management of Gastric Cancer: A Population-Based Analysis Paul J Karanicolas, MD, PhD, Elena B Elkin, PhD, Lindsay M Jacks, MSc, Coral L Atoria, MPH, Vivian E Strong, MD, FACS,
More informationThe Predictors and Clinical Impact of Positive Resection Margins on Frozen Section in Gastric Cancer Surgery
J Gastric Cancer 2012;12(2):113-119 http://dx.doi.org/10.5230/jgc.2012.12.2.113 Original Article The Predictors and Clinical Impact of Positive Resection Margins on Frozen Section in Gastric Cancer Surgery
More informationFactors Affecting Endoscopic Curative Resection of Gastric Cancer in the Population-Based Screening Era
ORIGINAL ARTICLE Clin Endosc 2018;51:478-484 https://doi.org/10.5946/ce.2018.006 Print ISSN 2234-2400 On-line ISSN 2234-2443 Open Access Factors Affecting Endoscopic Curative Resection of Gastric Cancer
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer March 2017 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationAssociation of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia
ADVANCES IN BIORESEARCH Adv. Biores., Vol 8 [3] May 2017: 137-141 2017 Society of Education, India Print ISSN 0976-4585; Online ISSN 2277-1573 Journal s URL:http://www.soeagra.com/abr.html CODEN: ABRDC3
More informationOutcomes of pancreaticoduodenectomy in patients with metastatic cancer
Korean J Hepatobiliary Pancreat Surg 2014;18:147-151 http://dx.doi.org/.14701/kjhbps.2014.18.4.147 Original Article Outcomes of pancreaticoduodenectomy in patients with metastatic cancer Joo Hwa Kwak,
More informationGastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors
Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors Jaume Capdevila, MD, PhD Vall d'hebron University Hospital Vall d'hebron Institute of Oncology (VHIO)
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationLong-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
Gut and Liver, Vol. 12, No. 2, March 218, pp. 133-141 ORiginal Article Long-Term ffects of Helicobacter pylori radication on Metachronous Gastric Cancer Development Seung Jun Han 1, Sang Gyun Kim 1, Joo
More informationChapter 13 Cancer of the Female Breast
Lynn A. Gloeckler Ries and Milton P. Eisner INTRODUCTION This study presents survival analyses for female breast cancer based on 302,763 adult cases from the Surveillance, Epidemiology, and End Results
More informationDiseases of the breast (2 of 2) Breast cancer
Diseases of the breast (2 of 2) Breast cancer Epidemiology & etiology The most common type of cancer & the 2 nd most common cause of cancer death in women 1 of 8 women in USA Affects 7% of women Peak at
More informationStudy of expression of P53 in Gastric Carcinoma As a prognostic indicator
Original Research Article Study of expression of P53 in Gastric Carcinoma As a prognostic indicator K. Padma Malini 1*, Srivani 2, O. Shravan Kumar 3 1 Assistant Professor, 2 Associate Professor, 3 Professor
More informationNUMERATOR: Reports that include the pt category, the pn category and the histologic grade
Quality ID #100 (NQF 0392): Colorectal Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective
More informationThe association of and -related gastroduodenal diseases
The association of and -related gastroduodenal diseases N. R. Hussein To cite this version: N. R. Hussein. The association of and -related gastroduodenal diseases. European Journal of Clinical Microbiology
More informationEpidemiology of gastric cancer
1 Epidemiology of gastric cancer Mark E. Lockhart and Cheri L. Canon Introduction Although the incidence and mortality rate of gastric cancer are declining in the United States and Great Britain (Figures
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationChibueze Onyemkpa 1, Alan Davis 1, Michael McLeod 1, Tolutope Oyasiji 1,2. Original Article
Original Article Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile
More informationOriginal Article Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma
Int J Clin Exp Med 2015;8(5):7837-7842 www.ijcem.com /ISSN:1940-5901/IJCEM0003844 Original Article Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma Tingting Zhang, Dan
More informationCase Report Five-Year Survival after Surgery for Invasive Micropapillary Carcinoma of the Stomach
Case Reports in Surgery Volume 2013, Article ID 560712, 4 pages http://dx.doi.org/10.1155/2013/560712 Case Report Five-Year Survival after Surgery for Invasive Micropapillary Carcinoma of the Stomach Shigeo
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationRisk Factors and Tumor Recurrence in pt1n0m0 Gastric Cancer after Surgical Treatment
pissn : 293-582X, eissn : 293-5641 J Gastric Cancer 216;16(4):215-22 https://doi.org/1.523/jgc.216.16.4.215 Original Article Risk Factors and Tumor Recurrence in pt1nm Gastric Cancer after Surgical Treatment
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationGlasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma
Int Surg 2014;99:512 517 DOI: 10.9738/INTSURG-D-13-00118.1 Glasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma Tadahiro Nozoe, Rumi Matono,
More informationDifference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution
Surg Today (2014) 44:1685 1691 DOI 10.1007/s00595-013-0748-5 ORIGINAL ARTICLE Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution
More informationSECONDARIES: A PRELIMINARY REPORT
HPB Surgery, 1990, Vol. 2, pp. 69-72 Reprints available directly from the publisher Photocopying permitted by license only 1990 Harwood Academic Publishers GmbH Printed in the United Kingdom CASE REPORTS
More informationClinicopathological Characteristics and Outcome Indicators of Stage II Gastric Cancer According to the Japanese Classification of Gastric Cancer
Clinicopathological Characteristics and Outcome Indicators of Stage II Gastric Cancer According to the Japanese Classification of Gastric Cancer HITOSHI OJIMA 1, KEN-ICHIRO ARAKI 1, TOSHIHIDE KATO 1, KAORI
More informationClinical Study Small Bowel Tumors: Clinical Presentation, Prognosis, and Outcomein33PatientsinaTertiaryCareCenter
Hindawi Publishing Corporation Journal of Oncology Volume 2008, Article ID 212067, 5 pages doi:10.1155/2008/212067 Clinical Study Small Bowel Tumors: Clinical Presentation, Prognosis, and Outcomein33PatientsinaTertiaryCareCenter
More informationAkiko Serizawa *, Kiyoaki Taniguchi, Takuji Yamada, Kunihiko Amano, Sho Kotake, Shunichi Ito and Masakazu Yamamoto
Serizawa et al. Surgical Case Reports (2018) 4:88 https://doi.org/10.1186/s40792-018-0494-4 CASE REPORT Successful conversion surgery for unresectable gastric cancer with giant paraaortic lymph node metastasis
More information